HRSA-24-078: Fiscal Year 2024 Behavioral Health Service Expansion
Closed
This grant is closed. A newer notice from the same program is forecast: Fiscal Year (FY) 2027 Service Area Competition (SAC) (HRSA-27-009). Status: Expected deadline January 8, 2027. It is in our archive of Health Resources and Services Administration notices from 2024.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make about 400 awards worth $240 million in total. Applications closed on May 24, 2024.
From the official notice on Grants.gov, last changed May 7, 2024. Checked November 7, 2026.
- Total funding$240 million
- Expected awards400
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | April 22, 2024 |
|---|---|
| Deadline | May 24, 2024 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
You can apply if your organization is a Health Center Program award recipient6 with an active H80 grant award. We encourage health centers that do not currently provide behavioral health services to apply.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
This Notice of Funding Opportunity (NOFO) announces the opportunity to apply for funding under the fiscal year (FY) 2024 Behavioral Health Service Expansion (BHSE) program. BHSE will support health centers to increase access to behavioral health services through starting or expanding mental health and substance use disorder (SUD) services.
Who has won Health Center Program grants before
From fiscal 2021 to 2025, Health Center Program (93.224) awarded $21 billion across 4,197 grant awards, an average of $5.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Sun River Health, Inc. | New York | 4 | $103 million |
| Family Health Centers of San Diego Inc | California | 6 | $87.8 million |
| Yakima Valley Farm Workers Clinic | Washington | 3 | $84.5 million |
| Altamed Health Services Corporation | California | 5 | $82.6 million |
| Clinica Sierra Vista | California | 2 | $81.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-009, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-24-078 still open?
No. It closed on May 24, 2024. A newer notice is forecast: HRSA-27-009, expected deadline January 8, 2027.
Who can apply for Fiscal Year 2024 Behavioral Health Service Expansion?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Fiscal Year 2024 Behavioral Health Service Expansion?
Closed May 24, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $240 million in total across about 400 awards.
Who has won Health Center Program grants before?
The largest recipients over five fiscal years were Sun River Health, Inc., Family Health Centers of San Diego Inc, Yakima Valley Farm Workers Clinic. The program made 4,197 awards worth $21 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)